Profusa Expands Sales Footprint with New Distributor for Lumee™ Oxygen Platform in EuropeInitial target markets for commercialization include Germany, the Benelux countries, Austria, the United Kingdom, and Scandinavia
Profusa Invests Additional $1 Million in Digital Treasury AssetsBERKELEY, Calif, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (Nasdaq: PFSA), a commercial stage digital health company pioneering a next-generation technology platform enabling the continuous monitoring of an individual’s biochemistry, announces its second $1 million investment in digital treasury assets to hedge against macroeconomic uncertainties, in line with the Company’s treasury management strategy.
